Ittner, K. P. and Hossfeld, B. and Koppenberg, J. and Sefrin, P. (2013) PRAC Will Re-Examine its Recommendation Regarding Hydroxyethyl-Starch (HES) Solutions. NOTARZT, 29 (4). pp. 163-166. ISSN 0177-2309, 1438-8693
Full text not available from this repository. (Request a copy)Abstract
At the request of the German Federal Institute for Drugs and Medical Devices (BfArM), the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) has initiated a review procedure regarding the basic evaluation of the benefit-risk balance of solutions for infusion containing hydroxyethyl starch (HES). Here we present an overview of facts to provide emergency physicians objective information.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | ; emergency medicine; drug therapy; patient safety; pharmacovigilance; hydroxyethyl starch |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Anästhesiologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 02 Apr 2020 12:41 |
| Last Modified: | 02 Apr 2020 12:41 |
| URI: | https://pred.uni-regensburg.de/id/eprint/16249 |
Actions (login required)
 |
View Item |
